Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(1995): Hertl M+, Br J Dermatol 132, 215
(1995): Wolkenstein P+, Arch Dermatol 131, 544
(1994): Litt JZ, Beachwood, OH (personal case) (observation)
(1993): Agarwal BR+, Indian Pediatr 30, 1026
(1993): Litt JZ, Beachwood, OH (personal case) (observation)
(1993): Malnick SDH+, Ann Pharmacotherapy 27, 1139
(1990): Medina I+, NEnglJMed323, 776 (47% in AIDS
patients)
(1988): DeRaeve L+, Br J Dermatol 119, 521 (in AIDS patient)
(1988): Fihn SD+, AnnInternMed108, 350 (1–5%)
(1988): Sattler FR+, AnnInternMed109, 280 (44% in AIDS
patients)
(1988): Weinke T+, Dtsch Med Wochenschr (German) 113, 1129
(25% in AIDS patients)
(1987): Goa KL+, Drugs 33, 242 (65% in AIDS patients)
(1987): Schöpf E, Infection 15 (Suppl 5P), S254
(1986): Sonntag MR+, Schweiz Med Wochenschr (German)
116, 142
(1985): DeHovitz JA+, AnnInternMed103, 479
(1985): Maayan S+, Arch Intern Med 145, 1607
(1984): Gordon FM+, AnnInternMed100, 495 (51% in AIDS
patients)
(1984): Kovacs JA+, AnnInternMed100, 663 (29% in AIDS
patients)
(1983): Mitsuyasu R+, NEnglJMed308, 1535 (69% in AIDS
patients.)
(1982): Goetz MB+, JAMA 247, 3118
(1980): Fennell RS+, Clin Pediatr 19, 124
Exfoliative dermatitis
(1990): Ponte CD+, Drug Intell Clin Pharm 24, 140 (feet)
Fixed eruption
(2007): Prescrire Int 16(87), 21 (with trimethoprim)
(2006): Rasi A+, Dermatol Online J 12(6), 12 (with trimethoprim)
(2004): Tornero P+, Contact Dermatitis 51(2), 57
(1997): Gruber F+, Clin Exp Dermatol 22, 144
(1996): Sharma VK+, JDermatol23, 530
(1995): Wolkenstein P+, Arch Dermatol 131, 544
(1993): Oleaga JM+, Contact Dermatitis 29, 155
(1993): Ramam M+, Indian Pediatr 30, 110 (in an infant)
(1992): Lim JT+, Ann Acad Med Singapore 21, 408
(1991): Jain VK+, Ann Dent 50, 9 (oral mucous membrane)
(1991): Smoller BR+, JCutanPathol18, 13
(1990): Gaffoor PMA+, Cutis 45, 242 (genitalia)
(1989): Basomba A+, J Allergy Clin Immunol 84, 409
(1989): Bharija SC+, Australas J Dermatol 30, 43
(1989): Gupta R, Indian J Dermatol 55, 181 (in an infant)
(1989): Varsano I+, Dermatologica 178, 232
(1988): Baird BJ+, Int J Dermatol 27, 170 (bullous and
generalized)
(1988): Bharija SC+, Dermatologica 176, 108 (in an infant)
(1987): Amir J+, Drug Intell Clin Pharm 21, 41
(1987): Hughes BR+, Br J Dermatol 116, 241
(1987): Van Voorhees A+, Am J Dermatopathol 9, 528
(1986): Kanwar AJ+, Dermatologica 172, 230
(1985): Gomez B+, Allergol Immunopathol Madr (Spanish) 13, 87
(1984): Pandhi RK+, Sex Transm Dis 11, 164
(1982): Gibson JR, BMJ 284, 1529
(1980): Talbot MD, Practitioner 224, 823
Lichenoid eruption
(1994): Berger TG+, Arch Dermatol 130, 609
Linear IgA dermatosis
(2003): Avci O+, JAmAcadDermatol48(2), 299 (passim)
(1994): Kuechle MK+, JAmAcadDermatol30, 187
Lupus erythematosus
(1985): Stratton MA, Clin Pharm 4, 657
Photo-recall
(1990): Leslie MD+, Br J Radiol 63, 661
(1987): Vukelja SJ+, Cancer Treat Rep 71, 668 (at previously
irradiated area)
SULFAMETHOXAZOLE 511
(1984): Shelley WB+, JAmAcadDermatol11, 53 (at site of
previous sunburn)
Photosensitivity (>10%)
(1994): Berger TG+, Arch Dermatol 130, 609 (in HIV-infected) (4
cases)
(1994): Shelley WB+, Cutis 53, 162 (observation)
(1987): Schöpf E, Infection 15 (Suppl 5P), S254
(1986): Chandler MJ, JInfectDis153, 1001
Pruritus (10%)
(1997): Caumes E+, Arch Dermatol 133, 465
(1997): Thaler D, Monona, WI (from Internet) (observation)
(1996): Litt JZ, Beachwood, OH (personal case) (observation)
(1990): Medina I+, NEnglJMed323, 776 (1–5%)
(1987): Colebunders R+, AnnInternMed107, 599 (4% in AIDS
patients)
(1986): Sher MR, J Allergy Clin Immunol 77, 133
(1984): Kramer BS+, Cancer 53, 329
Pruritus ani et vulvae
(1981): Modern Medicine 49, 111
Psoriasis
Purpura
(1993): Kaufman DW+, Blood 82, 2714
(1989): Saxena SK, J Assoc Physicians India 37, 479
Pustules
(1994): Spencer JM+, Br J Dermatol 130, 514
(1990): Guy C+, Nouv Dermatol (French) 9, 540
(1989): Grattan CEH, Dermatologica 179, 57 (passim)
(1986): Macdonald KJS+, BMJ 293, 1279
Rash (sic) (>10%)
(2006): Hemstreet BA+, Pharmacotherapy 26(4), 551 (with
trimethoprim)
(1995): Williams JW+, JAMA 273, 1015
(1993): Malnick SD+, Ann Pharmacother 27, 1139
Side effects (sic) (2%)
(1994): Roudier C+, Arch Dermatol 130, 1383 (48% in AIDS
patients)
Stevens–Johnson syndrome (1–10%)
(2006): Hemstreet BA+, Pharmacotherapy 26(4), 551 (with
trimethoprim)
(1997): Douglas R+, Clin Infect Dis 25, 1480
(1997): Rieder MJ+, Pediatr Infect Dis J 16, 1028 (10% in
children with HIV)
(1996): Caumes E, Rev Mal Respir (French) 13, 101
(1996): McCarty J, Fort Worth, TX (from Internet) (observation)
(1995): Kuper K+, Ophthalmologe (German) 92, 823
(1995): Sharma VK+, Pediatr Dermatol 12, 178
(1995): Wolkenstein P+, Arch Dermatol 131, 544
(1994): Shelley WB+, Cutis 53, 159 (observation)
(1993): Litt JZ, Beachwood, OH (personal case) (observation)
(1990): Chan HL+, Arch Dermatol 126, 43
(1988): Platt R+, JInfectDis158, 474
(1985): Heer M+, Gastroenterology 88, 1954
(1982): Brettle RP+, JInfect4, 149
Toxic epidermal necrolysis (1–10%)
(2002): Nassif A+, J Invest Dermatol 118(4), 728
(2001): See S+, Ann Pharmacother 35(6), 694
(2000): Moussala M+, JFrOphtalmol(French) 23, 229
(1996): Caumes E, Rev Mal Respir 13, 101
(1996): Rehbein H, Jacksonville, FL (from Internet) (observation)
(1995): Sharma VK+, Pediatr Dermatol 12, 178
(1995): Wolkenstein P+, Arch Dermatol 131, 544 (7 cases)
(1993): Correia O+, Dermatology 186, 32
(1990): Chan HL+, Arch Dermatol 126, 43
(1990): Kobza Black A+, Br J Dermatol 123, 277
(1990): Roujeau JC+, Arch Dermatol 126, 37
(1990): Ward DJ+, Burns 16, 97
(1989): Carmichael AJ+, Lancet 2, 808
(1989): Whittington RM, Lancet 2, 574
(1988): De Raeve L+, Br J Dermatol 119, 521 (passim)